These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

86 related items for PubMed ID: 3162016

  • 1. Effects of the calcium antagonists perhexiline and cinnarizine on vascular and cardiac contractile protein function.
    Silver PJ, Dachiw J, Ambrose JM, Pinto PB.
    J Pharmacol Exp Ther; 1985 Sep; 234(3):629-35. PubMed ID: 3162016
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Phosphorylation of cardiac myosin light chain 2 by protein kinase C and myosin light chain kinase increases Ca(2+)-stimulated actomyosin MgATPase activity.
    Noland TA, Kuo JF.
    Biochem Biophys Res Commun; 1993 May 28; 193(1):254-60. PubMed ID: 8503915
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Potent stimulation of myofilament force and adenosine triphosphatase activity of canine cardiac muscle through a direct enhancement of troponin C Ca++ binding by MCI-154, a novel cardiotonic agent.
    Kitada Y, Kobayashi M, Narimatsu A, Ohizumi Y.
    J Pharmacol Exp Ther; 1989 Jul 28; 250(1):272-7. PubMed ID: 2545860
    [Abstract] [Full Text] [Related]

  • 9. Wy-46,300 and Wy-46,531: vascular smooth muscle relaxant/antihypertensive agents with combined Ca2+ antagonist/myosin phosphorylation inhibitory mechanisms.
    Silver PJ, Sulkowski TS, Lappe RW, Wendt RL.
    J Cardiovasc Pharmacol; 1986 Jul 28; 8(6):1168-75. PubMed ID: 2434743
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Adenosine 3':5'-monophosphate-mediate inhibition of activities of the superprecipitation and the actin-activated Mg2+-ATPase of bovine arterial myosin in the presence of arterial native tropomyosin.
    Nosaka S, Shibata N, Yoshikawa K.
    Med J Osaka Univ; 1984 Sep 28; 35(1-2):1-12. PubMed ID: 6152008
    [No Abstract] [Full Text] [Related]

  • 19. On the role of Ca++ binding proteins as possible targets for Ca++ sensitizing agents.
    Herzig JW, Quast U.
    Z Kardiol; 1992 Sep 28; 81 Suppl 4():49-55. PubMed ID: 1290306
    [Abstract] [Full Text] [Related]

  • 20. Ca2+, calmodulin and cyclic AMP-dependent modulation of actin-myosin interactions in aorta.
    Silver PJ, Holroyde MJ, Solaro RJ, Disalvo J.
    Biochim Biophys Acta; 1981 Apr 17; 674(1):65-70. PubMed ID: 6263347
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.